LAPLACE-TIMI 57 Primary Results A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of a Monoclonal Antibody to PCSK9 in Combination with a Statin in Patients with Hypercholesterolemia - PowerPoint PPT Presentation

1 / 15
} ?>
View by Category
About This Presentation
Title:

LAPLACE-TIMI 57 Primary Results A Double-blind, Randomized, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of a Monoclonal Antibody to PCSK9 in Combination with a Statin in Patients with Hypercholesterolemia

Description:

TIMI Study Group, Cardiovascular Division . Brigham and Women s Hospital. ... resulting in dissociation of the LDLs from LDLRs due to the acidic environment.1. – PowerPoint PPT presentation

Number of Views:87
Avg rating:3.0/5.0

less

Write a Comment
User Comments (0)
About PowerShow.com